248 related articles for article (PubMed ID: 23558962)
1. microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report.
Kowalewska M; Bakula-Zalewska E; Chechlinska M; Goryca K; Nasierowska-Guttmejer A; Danska-Bidzinska A; Bidzinski M
Tumour Biol; 2013 Aug; 34(4):2153-60. PubMed ID: 23558962
[TBL] [Abstract][Full Text] [Related]
2.
de Almeida BC; Dos Anjos LG; Uno M; Cunha IWD; Soares FA; Baiocchi G; Baracat EC; Carvalho KC
Cells; 2019 Nov; 8(11):. PubMed ID: 31744257
[TBL] [Abstract][Full Text] [Related]
3. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
Rommel B; Holzmann C; Bullerdiek J
Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
[TBL] [Abstract][Full Text] [Related]
4. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
5. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
[TBL] [Abstract][Full Text] [Related]
6. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
7. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract][Full Text] [Related]
8. Clinical and subclinical endometritis induced alterations in bovine endometrial transcriptome and miRNome profile.
Salilew-Wondim D; Ibrahim S; Gebremedhn S; Tesfaye D; Heppelmann M; Bollwein H; Pfarrer C; Tholen E; Neuhoff C; Schellander K; Hoelker M
BMC Genomics; 2016 Mar; 17():218. PubMed ID: 26965375
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
10. Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
Gonzalez Dos Anjos L; de Almeida BC; Gomes de Almeida T; Mourão Lavorato Rocha A; De Nardo Maffazioli G; Soares FA; Werneck da Cunha I; Baracat EC; Carvalho KC
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30200635
[TBL] [Abstract][Full Text] [Related]
11. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.
Ravid Y; Formanski M; Smith Y; Reich R; Davidson B
Gynecol Oncol; 2016 Mar; 140(3):512-7. PubMed ID: 26768834
[TBL] [Abstract][Full Text] [Related]
13. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.
Biamonte F; Santamaria G; Sacco A; Perrone FM; Di Cello A; Battaglia AM; Salatino A; Di Vito A; Aversa I; Venturella R; Zullo F; Costanzo F
Sci Rep; 2019 Apr; 9(1):5668. PubMed ID: 30952937
[TBL] [Abstract][Full Text] [Related]
15. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer].
Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA
Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000
[TBL] [Abstract][Full Text] [Related]
16. Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC; Bennett JA
Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
[TBL] [Abstract][Full Text] [Related]
17. Functionality of the Tumor Suppressor
Stope MB; Cernat V; Kaul A; Diesing K; Koensgen D; Burchardt M; Mustea A
Anticancer Res; 2018 Mar; 38(3):1547-1550. PubMed ID: 29491084
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
19. microRNAs in oral cancer: Moving from bench to bed as next generation medicine.
D'Souza W; Kumar A
Oral Oncol; 2020 Dec; 111():104916. PubMed ID: 32711289
[TBL] [Abstract][Full Text] [Related]
20. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
Busca A; Parra-Herran C
Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]